Potential Role of bcl-2 and Ki-67 Expression and Apoptosis in Colorectal Carcinoma: A Clinicopathologic Study

Digestive Diseases and Sciences

Volumn 48, Issue 10, 2003, Pages 1990-1997

  Scopa, Chrisoula D ^a,b   Tsamandas, Athanassios C ^a   Zolota, Vicky ^a   Kalofonos, Haralabos P ^a   Batistatou, Anna ^a   Vagianos, Constantine ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Apoptosis; bcl 2; Colorectal carcinoma; Ki 67; Prognostic factors

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0242486774     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026178506348     Document Type: Article

References (40)

1. Rosai J: Ackerman's Surgical Pathology, 8th ed, Vol. 1. St. Louis, Mosby, 1996
2. Bosman FT, Visser BC, van Oeveren J: Apoptosis: pathophysiology of programmed cell death. Pathol Res Pract 192:676-683, 1996
3. Cummings MC, Winterford CM, Walker NI: Apoptosis. Am J Surg Pathol 21:88-101, 1997
4. Staunton MJ, Gaffney EF: Apoptosis. Basic concepts and potential significance in human cancer. Arch Pathol Lab Med 122:310-319, 1998
5. Geske FJ, Gerschenson LE: The biology of apoptosis. Hum Pathol 32:1029-1038, 2001
6. Cleary ML, Sklar J: Nucleotide sequence of a t (14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a break-point cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443, 1985
7. Lu QL, Abel P, Foster CS, Lalani EN: Bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27:102-110, 1996
8. Krawejski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res 53:4701-4714, 1993
9. Soini Y, Paakko P, Letho V-P: Histopathological evaluation of apoptosis in cancer. Am J Pathol 153:1041-1053, 1998
10. Scopa CD, Vagianos C, Kardamakis D, Kourelis TG, Kalofonos HP, Tsamandas AC: Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Appl Immunohistochem Mol Morphol 9:329-334, 2001
11. Diebold J, Baretton G, Felchner M, Meier W, Dopfer K, Schmidt M, Lohrs U. Bcl-2 expression, p53 accumulation and apoptosis in ovarian carcinomas. Am J Clin Pathol 105:341-349, 1996
12. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pietce CB, Harris A, Gatter KC, Mason DY: Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
13. Bubendorf L, Sauter G, Moch H, Jordan P, Blochlinger A, Gasser TC, Mihatsch MJ: Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557-1565, 1996
14. Saegusa M, Takano Y, Hashimura M, Okayasu I, Shiga J: The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 76:2297-2303, 1995
15. Karamitopoulou E, Perentes E, Tolnay M, Probst A: Prognostic significance of MIB-1, p53 and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140-145, 1998
16. Koshida Y, Saegusa M, Okayasu I: Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 75:367-373, 1997
17. Scopa CD, Vagianos C, Kourelis T, Tsamandas AC: The potential role of bcl-2, p53 and bax expression in rectal adenocarcinoma and their correlation with tumor prognosis. Eur Surg Res 32(suppl 1):7, 2000
18. Kaklamanis L, Savage A, Whitehouse R, Doussis-Anagnostopoulou I, Biddolph S, Tsiotos P, Mortensen N, Gatter KC, Harris AL: Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer 77:1864-1869, 1998
19. Sinicrope FA, Hart J, Michelassi F, Lee JJ: Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin Cancer Res 1:1103-1110, 1995
20. Scott RJ, Hall PA, Haldane JS, van Noorden S, Price Y, Lane DP, Wright NA: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173-178, 1991
21. Kruger S, Muller H: Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki-67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 75:480-484, 1995
22. Jass JR, Sobin LH: Histological Typing of Intestinal Tumors: World Health Organization, 2nd ed. New York, Springer-Verlag, 1989
23. Saleh HA, Jackson H, Khatib G, Banerjee M: Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. Pathol Oncol Res 5:273-279, 1999
24. Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Coggi G, Viale G: Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 26:534-540, 1995
25. Nakamura T, Nomura S, Sakai T, Nariya S: Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their pre-malignant lesions. Hum Pathol 28:309-315, 1997
26. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965, 1991
27. Stewart BW: Mechanism of apoptosis: integration of genetic, biochemical and cellular indications. J Natl Cancer Inst 86:1286-1298, 1994
28. Miyashita T, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805, 1994
29. Haldar S, Negrini M, Monne M, Sabbioni S, Crose CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097, 1994
30. Boise LH, Gonzales-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
31. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homologue BAX that accelerates cell death. Cell 74:609-619, 1993
32. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Stivastava S, Grizzle WE: Prognostic significance of bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74:346-358, 1997
33. Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, Doctor SS, Shah NG, Balar DB: Co-expression of bcl-2, c-Myc and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum 40:785-590, 1997
34. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, Papadimitriou C, Georgoulias V, Gatter KC, Bizakis JG, Retalis G, Karkavitsas N, Helidonis ES: Combined role of tumor angiogenesis, bcl-2 and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 86:1421-1430, 1999
35. Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonk JH: Immunohistochemical detection of p53 and bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 77:1842-1847, 1998
36. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale C: The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to estrogen receptor status. Virchows Arch 424:47-51, 1994
37. Saegusa M, Takano Y, Okayasu I: Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 121:357-363, 1995
38. Tabete S, Ishida M, Kasagi N, Tsujitanis S, Kaibara N, Ito H: Apoptosis occurs more frequent in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase- mediated dUTP-biotin nick end labeling. Int J Cancer 65:173-177, 1996
39. Takano Y, Saegusa M, Ikenaga M, Mitomi H, Okayasu I: Apoptosis in colon cancer: comparison with Ki-67 proliferative activity and expression of p53. J Cancer Res Clin Oncol 122:166-170, 1996
40. Ioffe OB, Papadimitriou JC, Drachenberg CB: Correlation of proliferation indices, apoptosis and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic and malignant endometrium. Hum Pathol 29:1150-1159, 1998